Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 USD | -9.20% | -16.85% | -49.83% |
05-09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.83% | 55.55M | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+3.35% | 22.82B | |
-10.46% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- Mizuho Downgrades BioXcel Therapeutics to Neutral From Buy Amid Restructuring and Strategic Reprioritization, Slashes Price Target to $4 From $40